Literature DB >> 17055725

Intermediate analogue inhibitors of mandelate racemase: N-Hydroxyformanilide and cupferron.

Jennifer R Bourque1, Rodney K M Burley, Stephen L Bearne.   

Abstract

Mandelate racemase (MR) catalyzes the 1,1-proton transfer that interconverts the enantiomers of mandelate. The transition state/intermediate analogues N-hydroxyformanilide (K(i)=2.79+/-0.19 microM) and cupferron (K(i)=2.67+/-0.09 microM) are identified as potent competitive inhibitors of MR. The pH-pK(i) profile indicates that MR can bind either the protonated or deprotonated forms of N-hydroxyformanilide, with a 10-fold greater affinity for the latter form.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055725     DOI: 10.1016/j.bmcl.2006.09.079

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Structure of mandelate racemase with bound intermediate analogues benzohydroxamate and cupferron.

Authors:  Adam D Lietzan; Mitesh Nagar; Elise A Pellmann; Jennifer R Bourque; Stephen L Bearne; Martin St Maurice
Journal:  Biochemistry       Date:  2012-02-03       Impact factor: 3.162

2.  Hydroxamic Acid as a Potent Metal-Binding Group for Inhibiting Tyrosinase.

Authors:  Joonhyeok Choi; Trilok Neupane; Rishiram Baral; Jun-Goo Jee
Journal:  Antioxidants (Basel)       Date:  2022-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.